Cost-Effectiveness of denosumab vs. Brand or generic zoledronic acid in patients with prostate cancer in kazakhstan
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.333
https://www.valueinhealthjournal.com/article/S1098-3015(14)02263-3/fulltext
Title :
Cost-Effectiveness of denosumab vs. Brand or generic zoledronic acid in patients with prostate cancer in kazakhstan
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)02263-3&doi=10.1016/j.jval.2014.08.333
First page :
A773
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2326